chrisvoncsefalvay/vaers-outcomes huggingface dataset:
puffiness and itchiness around her upper eye/last night she had a puffing, her eyes were puffed; it was itchy and she experienced itchiness everywhere/itchiness around her upper eye; This is a spontaneous report from a contactable consumer (patient herself). A 33-year-old female patient received first dose of bnt162b2 (BNT162B2, lot number: EK5730), intramuscular on Dec2020 at single dose for COVID-19 immunization. The patient has no medical history and stated that she had no other medical conditions, stated that she was generally healthy. Concomitant medication included ibuprofen and paracetamol (TYLENOL). The patient received the bnt162b2 and she had a puffing, her eyes were puffed, the upper eye and it was itchy and she experienced itchiness everywhere on an unspecified date in Dec2020. Patient mentioned that there was no rash or hives. She said she took Benadryl and it helped with the puffiness around the eyes, it did help with itchiness but she was still having some itchiness so she wanted to go just ahead and report that to our safety department. Patient clarified that Benadryl helped with the puffiness around her eyes but the itching part was still there, it (Benadryl) helped but not that much. Patient reported that she had a CBC recently and she got her antibodies checked few days before she got the vaccine. Patient reported that there were some mild generalized itchiness. It was just mild right now. Outcome of eyes were puffed was recovering while outcome of itchiness  was not recovered.
Pt had syncopal episode within 5 minutes of receiving vaccine. Lost consciousness and slumped to floor. RPh was able to elevate feet and pt came around promptly, declined offer to call 911 or a friend/relative. Reported lightheadedness, no nausea or other symptoms. RPh provided water and sat with patient until they were able to sit comfortably. Ascertained pt had not eaten anything all day and went to get Gatorade, which seemed to help. Pt was monitored another 20 minutes until they felt well and left.
mom returns pt 30 hrs p/vax w/lt arm red, hard, burn to touch, non tender-stated noticed reaction this AM;
On 06/20/2022 he tested positive for Covid. Still has a slight cough. Breakthrough case.
first dose of BNT162B2 on 20Dec2020 and second dose of BNT162B2 on 15Jan2021; left axillary swelling, tenderness; headache; left axillary swelling; fatigue; chills; fever; This is a spontaneous report from a contactable healthcare professional. A 37-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), intramuscular in left arm on 15Jan2021 13:00 at single dose for COVID-19 immunization.  Medical history included hypertension (HTN) and tomatoes, egg whites and milk-related products allergy; all from an unknown date and unknown if ongoing. Concomitant medication included hctz, metoprolol and ibuprofen. The patient previously had first dose of BNT162B2 lot number: EJ1685, on 20Dec2020 01:00 PM at single dose for COVID-19 immunization. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 16Jan2021, the patient experienced fatigue, fever and chills. On 17Jan2021, the patient experienced headache and left axillary swelling. On 20Jan2021,on follow up in the office, the patient experienced left axillary swelling, tenderness without lymphadenopathy or erythema. The injection site without redness or localized swelling. The events resulted in doctor or other healthcare professional office/clinic visit. It was reported that the patient received first dose of BNT162B2 on 20Dec2020 and second dose of BNT162B2 on 15Jan2021. The outcome of the events was unknown. No treatment was given to the patient for the events.
Febrile seizure, probable vaccine related. Tonic convulsion by postictal limping. Tylenol and cooling measures done at home, temperatures from 102.6 - 103.9.
About 2.5 hours  after shingles vaccination I felt very awkward, had a clumsy walk, fell to pavement.  My blood glucose level was normal.  3.5 hours later I had diarrhea.
Localized erythema, induration, tenderness to palptation, and itching that has spread in past 24 hours.
"Moderna COVID-19 Vaccine EUA" 4 weeks after 1st dose: 1) "Covid arm" persists but with less redness after 2xd application of Hydrocortisone cream USP 2.5%; 2) Itching rashes mainly in scalp, but  face, neck and upper body also show red dots of rash. These all persist despite antihistamines: Zyrtec (OTC) once a day; and occasionally Hydroxyzine HCl 25 mg doctor's prescription. Rosacea is more predominant. Today I took the 2nd dose of Moderna. Will report again if those symptoms continue.
Information has been received through the pregnancy Registry for GARDASIL from a nurse concerning a 20 year old  female with no pertinent medical history and no history of drug reactions or allergies who on 04-Feb-2008 was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL. On 07-May-2008 the patient had her last menstrual period. On 29-May-2008 the patient was vaccinated intramuscularly with the second 0.5ml dose of GARDASIL (lot# 659964/1978U). Concomitant medication included doxycycline for the treatment of a chlamdia infection. On an unspecified date, a pregnancy test revealed the patient was pregnant. The patient had not experienced any known symptoms. On 07-Jul-2008, an ultrasound was performed, the results were within normal limits. The patient sought medical attention with a physician office visit. The patient was pregnant once previously, and it was a pre-term delivery. Follow up information has been received from a physician on 16-Feb-2009. It was reported that the 20 year old female patient was vaccinated on 14-Feb-2008 with the first dose of GARDASIL. The patient delivered a healthy baby on 06-Feb-2009. The pregnancy was normal except for induction for advance cervical dilation. On 16-Feb-2009, the patient was vaccinated with the third dose of GARDASIL. Additional information has been requested.
Information has been received from a physician concerning an 8 or 9 yr old male with diabetes who was vaccinated at 4 years of age with a dose of varicella virus vaccine live. On 06Sep05 the pt experienced a mild case of chickenpox. Subsequently, the pt recovered. It was noted that the father had developed shingles that required an ER prior to the child's outbreak. Unspecified medical attention was sought. No product quality complaint was involved. The pt's sister (WAES0510USA04275) also developed chicken pox after vaccination with varicella virus vaccine live. Additional information has been requested.
2 weeks after vaccine given pt developed significant redness, swelling on the spot where vaccine given.
Subsequent to receiving Tetanus and Diphtheria Toxoids Absorbed Purogenated the pt developed an injection site reaction characterized by a small area of induration, pain and a hard knot.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Shakiness-Mild, Additional Details: EMTs arrived, patient was already conscious on the floor with feet up, cleared to return home by EMT after checking vitals.
Vaccine on a Monday - following Monday afternoon low fever Tue. low fever, Wed 101 degrees Thur 101 degrees Fri evening rash on neck and chest, Sat neck chest back, of. Sunday include arms, Monday thighs, continued until Fri week later - possible shingles outbreak.
This patient arrived 03/2 for a Covid-19 shot.  The patient lives in a group home for residents with intellectual disabilities, and insisted he had been given the Covid-19 vaccine.  We looked in VAMS, called VAMS to verify that a dose had not been given, and contacted the homeless shelter where he had been found by the resident coordinator.  The patient had gone missing for a single day, and was dropped off by police officers at the shelter.  The shelter stated that no vaccinations had been done, but that the residents had all been tested for Covid-19 that day.  The resident coordinator believed that the resident had not received the shot, but was exhibiting
Sore arm; Body aches; Headaches; Nausea; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), HEADACHE (Headaches), NAUSEA (Nausea), PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced MYALGIA (Body aches), HEADACHE (Headaches), NAUSEA (Nausea), PAIN IN EXTREMITY (Sore arm), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, MYALGIA (Body aches), HEADACHE (Headaches), NAUSEA (Nausea), PAIN IN EXTREMITY (Sore arm), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Patient reported fever with temperature above 101 F along with flu like symptoms. Patient had a really bad shiver on Friday night. She was in pain, weak, and loss appetite for the whole day. She took ADVIL to relieve pain and fever. She gradually back to normal today.
NO ADVERSE REACTIONS REPORTED - MODERNA COIVD VACCINE WAS GIVEN OFF LABEL.  THE MANUFACTUERE AND BUREAU OF IMMUNIZATIONS WERE CONTACTED AND THE PATIENT REPORTS TO ADVERSE REACTIONS.
This spontaneous report as received from a pharmacist via a company representative refers to a 53 years old female patient. On 02-MAR-2015, the patient was vaccinated with ZOSTAVAX lot # K012785, expiration date 28-NOV-2015, 0.65 ml, subcutaneous. In approximately March 2015, the patient experienced fever as well as itching and redness of the injection site of her left arm after receiving ZOSTAVAX. The size of the redness at the injection site was measured to be 4.5 cm by 1 cm on an unspecified date, approximately in March 2015 and the redness increased to 20cm by 12cm on an unspecified date, approximately in March 2015. The patient was seen by her unspecified physician on 06-MAR-2015. The patient was administered a DECADRON shot (manufacturer unspecified) on 06-MAR-2015 by her unspecified physician and the patient was informed by the unspecified physician to take ibuprofen. The outcome of pyrexia, vaccination site erythema and vaccination site pruritus was unknown. Relatedness between the events and vaccination with ZOSTAVAX was not reported. Additional information has been requested.
Fever of 101.7 for 17 hours.  Aspirin did not reduce fever.  Injection site had a 5 inch band of purple all around it then it turned red like a sunburn.  The whole left shoulder swelled up.  Strong pain in all muscles and joints of the body.  Multiple hours of sleep for two days.
Given DTAP, IPV, MMRV and become cyanotic with decreased HR and BP.  Given oxygen and epinephrine and transported by EMS to hospital.
Client received COVID19 Pfizer 1st dose vaccine (Lot#FC3183) at 18:48 pm.  The client came to get vaccinated with her teenage son, and after receiving her injection, they both went to sit in the observation area.  At 19:05, the client expressed to EMT she feels a tingling sensation in her left forearm. EMT waived for Lead RN to come over. Lead RN asked the client if she was experiencing any shortness of breath, difficulty breath, or chest pain, to which the client responded, no. The client stated she had anxiety about getting the vaccine and it might just be nerves. She also stated she had been sitting for 15 minutes before it started. She said she has had her purse hanging on the forearm while in the observation area and that maybe the tingling came from finally removing her purse from her forearm. Lead RN asked the client if she has any underlying health conditions, takes any medications, and/or has any allergies, and the client responded no. The client stated her arm was already starting to feel better and the tingling was starting to go away. Lead RN asked the client if she felt the sensation in any other limbs or on any other part of her body, or if she had experienced any changes in vision. The client responded no. The client continued to state she was feeling fine and really believes it was just nerves. Lead RN educated client on both the potential side effects and adverse effects of the vaccine, when to seek medical attention, and ER precautions. Client stated she understood. Lead RN observed client and her son exit the observation room at 19:20 walking with a steady gait.
Patient began experiencing pain within a few hours after vaccination.  Treated with tyenol. Arm was very swollen and red by morning. Pt visited physician and measured arm for swelling. Arm was not swollen enough for emergency room but was very swollen and painful. Physician treated with rx for Septra DS and otc Zyrtec and Benadryl. The patient began improving over the course of the next few days but is still not returned to normal.
flu vaccine administered left arm-c/o pain when lifting arm up. arm throbs unless taking ibuprofen;shot hurt terribly when given.
first Shingrix vaccine September 2019. It has been more than six months; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix in September 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details provided were as follows: The patient was the reporter. The age at vaccination was not applicable for this report. Till the time of reproting, patient did not received 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter mentioned that it had been more than 6 months apart since patient received the 1st dose and it was almost 21 months. The reporter asked if I just get my 2nd vaccine now, or do I have to start over again and get two doses of Shingrix within a six month period.
redness and swelling in a 6x6 are to Right thigh where MMR vaccine was administered, swollen area was hot to touch and painful
supraventricular tachycardia, dizziness, chest pain. Brought to emergency room by ambulance and admitted to a cardiac telemetry unit for 7 days. Numerous tests and procedures performed, ie, echo, EPS, tilt table...  4/28/09 Received hospital medical records of 1/28-2/4/2009. FINAL DX: supraventricular tachycardia; vasovagal syncope Records reveal patient experienced palpitations upon awakening similar to prior episodes but she was unable to break out of it with vagal maneuvers.  Also had chest pain, SOB, diaphoresis, dizziness & nausea.  Admitted to CCU for monitoring.  Had couple of pre-syncope episodes while hospitalized.  No episodes of SVT on monitor.
1. left forearm ached 2. very tired 3. jittery 4. very cold  5. felt unlike my self for 2 days
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 09-FEB-2015 the patient was vaccinated with a dose of VARIVAX (Merck), 0.5 ml, subcutaneously (lot# was not reported) which underwent a supported temperature excursion. No adverse experience was reported. Additional information has been requested.
Sore arm for 2 days after shot. Day 8, "Covid Arm" - Delayed cutaneous hypersensitivity.   Red rash around injection area.  Warm to touch and slightly itchy.
Developed rash/urticaria.  Went to ER.  ER treated with steroids and Benadryl.  Patient improved significantly after treatment was initiated.  Still had mild urticaria this a.m. at office visit.
Patient with diffuse hives. Began surrounding injection site and spread over trunk extremities X 4. Treated with BENADRYL & PEPCID.
Soreness at the injection site; Pain and soreness in armpits and groin; Pain and soreness in armpits and groin; Headache; Fatigue; Muscle aches; This is a spontaneous report from a contactable other health care professional, the patient.  A 31-year old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248), intramuscular, in the left arm on 09Jan2021 at 08:00AM (at the age of 31-year-old) as a single dose for COVID-19 immunization.  Medical history included Penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. Historical vaccine included Dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 592671001), intramuscular, left arm  on 19Dec2020 for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Jan2021 at 18:00 PM, the patient experienced soreness at the injection site, pain and soreness in armpits and groin, headache, fatigue, muscle aches. The patient did not receive treatment for the events. The clinical outcome of the events soreness at the injection site, pain and soreness in armpits and groin, headache, fatigue, muscle aches was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Patient had swelling immediately after injection. Patient had a little bit of blood and the swelling was localized in a nodule where the immunization was injected.
Information has been received from a physician concerning a 20 year old female who on 16-MAR-2011 was vaccinated intramuscularly with a dose of PNEUMOVAX 23 (lot#668008/1157Z; exp date: 08-MAR-2012) in left arm. On an unknown date ("within an unspecified time frame"), the patient developed an injection site reaction. The injection site reaction was described as a swollen, warm and painful (sensitive to touch) area from the top of the arm to the elbow. The patient was treated with "soaks", BENADRYL and prednisone. It was unclear if the patient had received a previous vaccination with PNEUMOVAX 23. The patient returned to the office for follow up on 17-MAR-2011 and 18-MAR-2011. There was no lab diagnostics studies performed. At the time of the report, the patient had recovered from her adverse events. The patient sought medical attention via office visit. This is one of the several reports from the same source. Additional information has been requested.
Within 10 min after injection had pain in left side of neck and jaw. was given 800mg Ibuprofen and took for a few days. On Jan 6, 2021 supraclavicular swelling occurred near base of neck size of a baseball and lt neck pain. Saw physician on 1/8/21 and have soft tissue swelling
Pt recv vax & 3 wk later devel mumps; MD reported 2 pts;
The day after receiving the tdap vaccine, patient began to have an unquenchable thirst and the very frequent urge to urinate.  When he did urinate, he still had the sensation of needing to urinate more, but he never felt like he could empty his bladder completely. He also had a foot injury that failed to heal properly and became infected.  These symptoms continued for nearly a month until he was diagnosed with Type I diabetes on 8/24/07.  5/9/08 Reviewed Endocrinology medical records of 8/28/07-4/8/2008. FINAL DX: new onset Type I diabetes mellitus Records reveal patient experienced polyuria, polydipsia, fatigue & non healing wound for a few weeks prior to initial endocrine eval 8/28/2007.  Seen by PCP 8/27 where blood glucose was 254 w/(+)urine ketones.  Started on insulin that day & referred to endocrine.  Endocrine exam revealed 84th percentile height & 70th percentile weight.  Patient starting new school in 2 days.  5/13/08 Reviewed PCP office medical records of 8/24/2007-3/19/2008.  Tx w/insulin & referred to endocrinology. Eye exam 3/2008 WNL.
brief episode of heart palpitations and dizziness within an hour after injection. didn't experience this again until a brief episode in September 2022 and now many times since November 2022
sore arm; slept for 17 straight hours; chills; upset stomach; upper body flushing for up to 4 days later; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 16Jan2021 08:00 at single dose for COVID-19 immunization. Medical history included Known allergies to Possible latex, Diabetes, sleep apnea, PTSD (Post-traumatic stress disorder)/anxiety, herpes, vitamin d deficiency, environmental allergies, asthma. Concomitant medication was unspecified medication in two weeks. On 16Jan2021 08:00, The patient experienced sore arm, slept for 17 straight hours, chills, upset stomach, upper body flushing for up to 4 days later. Treatment received for the events included OTC medications. The patient was not pregnant. She had no COVID tested post vaccination. There was no other vaccine received in four weeks. The outcome of the events was recovered in 2021.   information on the lot/batch number has been requested.
Itchiness all over, dizziness, scratchy throat, hoarse voice, flushed skin on face. Within 15-30 mins of vaccine. Benadryl 50mg taken at 30 min mark.
What started everything was that I had gall stones. It caused an infection in my gall bladder and it spilled over into my blood stream. They treated the infection with antibiotics. I was in the hospital for about a week. I'm having surgery around 07/20 to have my gall bladder removed. They found that I have diabetes. They said that it could be from the gall stones and it may go away after the removal of my gall bladder.
Systemic: Confusion-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient had fainting episode immediately after  vaccine administration. She became responsive in few seconds. she said before fainting she felt tingling, rapid HR and really cold. she reports nausea and confusion right after becoming responsive. Mother denied the need for EMS said she is fine and she has had fainted once after flu shot. Her blood pressure was 100/62 and 95/82 with Heart rate of 99 and 89. She lied down for 30 minutes. she reported feeling fine before leaving.